Impact of CYP3A5 Polymorphisms on Pediatric Asthma Outcomes
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25126548 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Flory L Nkoy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Utah School of Medicine, 100 N. Mario Capecchi Drive, Salt Lake City, UT 84113, USA. Hauptthemen laut MEDLINE: Asthma, Polymorphism, Single Nucleotide, Cytochrome P-450 CYP3A, Adrenal Cortex Hormones. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NIGMS NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Genetic variation among inhaled corticosteroid (ICS)-metabolizing enzymes may affect asthma control, but evidence is limited. This study tested the hypothesis that single-nucleotide polymorphisms (SNPs) in Cytochrome P450 3A5 (CYP3A5) would affect asthma outcomes. Patients aged 2–18 years with persistent asthma were recruited to use the electronic AsthmaTracker (e-AT), a self-monitoring tool that records weekly asthma control, medication use, and asthma outcomes. A subset of patients provided saliva samples for SNP analysis and participated in a pharmacokinetic study. Multivariable regression analysis adjusted for age, sex, race, and ethnicity was used to evaluate the impact of CYP3A5 SNPs on asthma outcomes, including asthma control (measured using the asthma symptom tracker, a modified version of the asthma control test or ACT), exacerbations, and hospital admissions. Plasma corticosteroid and cortisol concentrations post-ICS dosing were also assayed using liquid chromatography–tandem mass spectrometry. Of the 751 patients using the e-AT, 166 (22.1%) provided saliva samples and 16 completed the PK study. The e-AT cohort was 65.1% male, and 89.6% White, 6.0% Native Hawaiian, 1.2% Black, 1.2% Native American, 1.8% of unknown race, and 15.7% Hispanic/Latino; the median age was 8.35 (IQR: 5.51–11.3) years. CYP3A5*3/*3 frequency was 75.8% in White subjects, 50% in Native Hawaiians and 76.9% in Hispanic/Latino subjects. Compared with CYP3A5*3/*3, the CYP3A5*1/*x genotype was associated with reduced weekly asthma control (OR: 0.98; 95% CI: 0.97–0.98; p < 0.001), increased exacerbations (OR: 6.43; 95% CI: 4.56–9.07; p < 0.001), and increased asthma hospitalizations (OR: 1.66; 95% CI: 1.43–1.93; p < 0.001); analysis of 3/*3, *1/*1 and *1/*3 separately showed an allelic copy effect. Finally, PK analysis post-ICS dosing suggested muted changes in cortisol concentrations for patients with the CYP3A5*3/*3 genotype, as opposed to an effect on ICS PK. Detection of CYP3A5*3/3, CYPA35*1/*3, and CYP3A5*1/*1 could impact inhaled steroid treatment strategies for asthma in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University of Utah School of Medicine, 100 N. Mario Capecchi Drive, Salt Lake City, UT 84113, USA.
- Department of Pharmacology and Toxicology, Center for Human Toxicology, University of Utah, 30 S 2000 E, Room 201 Skaggs Hall, Salt Lake City, UT 84112, USA.
ORCID-Profile: Cassandra E Deering-Rice, Joseph E Rower, Christopher A Reilly
Förderung
- NIEHS NIH HHS
- NIGMS NIH HHS
- NCATS NIH HHS
- National Institutes of Health, National Institute of General Medical Science
- National Institute of Environmental Health Sciences
Zitieren
APA
Nkoy, F. L., Stone, B. L., Deering-Rice, C. E., Zhu, A., Lamb, J. G., Rower, J. E., & Reilly, C. A. (2024). Impact of CYP3A5 Polymorphisms on Pediatric Asthma Outcomes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25126548
Vancouver
Nkoy FL, Stone BL, Deering-Rice CE, Zhu A, Lamb JG, Rower JE, et al. Impact of CYP3A5 Polymorphisms on Pediatric Asthma Outcomes. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25126548
BibTeX
@article{Nkoy2024,
author = {Nkoy, Flory L and Stone, Bryan L and Deering-Rice, Cassandra E and Zhu, Angela and Lamb, John G and Rower, Joseph E and Reilly, Christopher A},
title = {Impact of CYP3A5 Polymorphisms on Pediatric Asthma Outcomes},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25126548}
}
EUVIMED